Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSTONE PHARMA-B

3.570
+0.000
Volume:9.37M
Turnover:34.45M
Market Cap:4.58B
PE:-11.45
High:3.770
Open:3.600
Low:3.550
Close:3.570
Loading ...

CStone Pharmaceuticals - Under Partnership Pharmalink Will Gain Commercial Rights for Sugemalimab in Middle East, Others

THOMSON REUTERS
·
21 Nov 2024

CStone Pharmaceuticals - CStone & Pharmalink Enter Into Strategic Partnership for Sugemalimab in Middle East, North Africa Region & South Africa

THOMSON REUTERS
·
21 Nov 2024

CStone Drug Gets UK Approval for First-Line Treatment of Non-Small Cell Lung Cancer

MT Newswires Live
·
31 Oct 2024

CStone Announces Mhra Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (Nsclc) in the UK

THOMSON REUTERS
·
31 Oct 2024

Insiders Buying CStone Pharmaceuticals Might Wish They Invested More, Stock Gains 14%

Simply Wall St.
·
31 Oct 2024

BRIEF-Cstone Pharmaceuticals Receives MHRA Approval Of Sugemalimab For First-Line Treatment Of Non-Small Cell Lung Cancer In UK

Reuters
·
31 Oct 2024

CStone Pharmaceuticals - Mhra Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (Nsclc) in UK

THOMSON REUTERS
·
31 Oct 2024

BRIEF-UK's MHRA Says Sugemalimab Approved To Treat Adult Patients With Non-Small Cell Lung Cancer

Reuters
·
31 Oct 2024

UK's Mhra: Sugemalimab Approved to Treat Adult Patients With Non-Small Cell Lung Cancer

THOMSON REUTERS
·
31 Oct 2024

BRIEF-CStone Pharmaceuticals Announces Further Increase In Shareholding By CEO

Reuters
·
23 Oct 2024

CStone Pharmaceuticals CEO Raises Stake

MT Newswires Live
·
23 Oct 2024

CStone Pharmaceuticals - Further Increase in Shareholding by CEO by 2.3 Mln Shares

THOMSON REUTERS
·
23 Oct 2024

CStone Pharmaceuticals Gets Patent Publish for Internally Developed Cancer Drug; Shares Down 3%

MT Newswires Live
·
21 Oct 2024

BRIEF-CStone Pharmaceuticals Says Patent Publication For CS5006

Reuters
·
21 Oct 2024

CStone Pharmaceuticals - Patent Publication for First-in-Class Antibody-Drug Conjugate (ADC) Cs5006

THOMSON REUTERS
·
21 Oct 2024

CStone Pharmaceuticals Initiates Phase III Clinical Trial for Hepatocellular Carcinoma Drug

MT Newswires Live
·
02 Oct 2024